189,192 Shares in The Cooper Companies, Inc. (NASDAQ:COO) Bought by Universal Beteiligungs und Servicegesellschaft mbH

Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 189,192 shares of the medical device company's stock, valued at approximately $17,392,000. Universal Beteiligungs und Servicegesellschaft mbH owned about 0.09% of Cooper Companies as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also recently made changes to their positions in the business. Byrne Asset Management LLC purchased a new position in Cooper Companies in the 4th quarter worth approximately $33,000. OFI Invest Asset Management purchased a new position in Cooper Companies in the 4th quarter worth approximately $34,000. New Age Alpha Advisors LLC purchased a new position in Cooper Companies in the 4th quarter worth approximately $38,000. Covestor Ltd raised its holdings in Cooper Companies by 35.5% in the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock worth $42,000 after acquiring an additional 120 shares during the last quarter. Finally, Atala Financial Inc purchased a new position in Cooper Companies in the 4th quarter worth approximately $51,000. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Cooper Companies Stock Performance

Shares of COO stock traded down $0.09 during mid-day trading on Tuesday, reaching $66.91. 4,101,096 shares of the company's stock traded hands, compared to its average volume of 1,556,510. The Cooper Companies, Inc. has a 12 month low of $65.00 and a 12 month high of $112.38. The firm has a 50 day moving average price of $79.12 and a two-hundred day moving average price of $87.91. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The firm has a market capitalization of $13.38 billion, a PE ratio of 34.31, a price-to-earnings-growth ratio of 2.25 and a beta of 1.08.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings data on Thursday, May 29th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.93 by $0.03. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The firm had revenue of $1 billion during the quarter, compared to the consensus estimate of $995.12 million. During the same quarter in the previous year, the firm posted $0.85 EPS. The company's revenue for the quarter was up 6.3% compared to the same quarter last year. On average, research analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on COO. Citigroup decreased their price objective on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating for the company in a report on Friday, March 7th. Stifel Nicolaus decreased their target price on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating for the company in a research note on Friday, March 7th. Wall Street Zen upgraded shares of Cooper Companies from a "hold" rating to a "buy" rating in a research note on Friday. Robert W. Baird decreased their target price on shares of Cooper Companies from $107.00 to $97.00 and set an "outperform" rating for the company in a research note on Friday. Finally, Needham & Company LLC reiterated a "hold" rating on shares of Cooper Companies in a research note on Thursday, May 22nd. Four investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat.com, Cooper Companies has a consensus rating of "Moderate Buy" and an average price target of $100.38.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.